NeuCyte, Inc.

Industry

  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Therapeutic Drug Monitoring
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
      • ADMET
  • Pharmaceuticals
See more in Biomedtracker

Latest on NeuCyte, Inc.

Medtech Insight

Pacts In Medtech: BI, Inflammasome Work On Retinal Disease; Takeda And Prometheus Take On IBD

 
• By Reed Miller

Deals In September BI, Inflammasome Ally In $160m Retinal Diseases Collaboration Boehringer Ingelheim International GmbH and Inflammasome Therapeutics Inc. agreed to co-develop up to three candida

Scrip

Deal Watch: Another Delay For Roche/Spark, While FTC Ups AbbVie/Allergan Merger Scrutiny

 
• By Joseph Haas and Eleanor Malone

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Roche Pushes Back Deadline A

Scrip

Venture Funding Deals: Two Companies With China Ties Raise $260m Each

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar